NCT02931500 is a clinical trial in Cardiovascular Disease, sponsored by Yonsei University.

Who is sponsoring NCT02931500?

NCT02931500 is sponsored by Yonsei University.

What condition does NCT02931500 study?

NCT02931500 studies Cardiovascular Disease, Metabolic Disease.

Is NCT02931500 still recruiting?

NCT02931500 is currently status unknown. Last updated 10 January 2018.

Last reviewed 2018-01-10 · How we verify

NCT02931500

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Machine Learning for Identification of Future Disease Development: A Nationwide Cohort Study (MILESTONE)

Status unknown Last updated 10 January 2018

What this trial tests

trial in Cardiovascular Disease in 510,000 participants. Status unknown.

Timeline

1 July 2016

Primary endpoint
30 October 2018

31 December 2018

Quick facts

Lead sponsor	Yonsei University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	510,000
Start date	1 July 2016
Primary completion	30 October 2018
Estimated completion	31 December 2018
Sites	1 location across South Korea

Conditions studied

Cardiovascular Disease — all drugs for Cardiovascular Disease →
Metabolic Disease — all drugs for Metabolic Disease →

Sponsor

Yonsei University

Who can join

18 and older, any sex, with Cardiovascular Disease or Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop machine learning algorithms for the identification of future development of cardiovascular and metabolic disease

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Incremental Value of Repeated Risk Factor Measurements for Cardiovascular Disease Prediction in Middle-Aged Korean Adults: Results From the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort).
Cho IJ, Sung JM, Chang HJ, Chung N, et al · · 2017 · cited 16× · PMID 29150537 · DOI 10.1161/circoutcomes.117.004197
Development and External Validation of a Deep Learning Algorithm for Prognostication of Cardiovascular Outcomes.
Cho IJ, Sung JM, Kim HC, Lee SE, et al · · 2020 · cited 8× · PMID 31456363 · DOI 10.4070/kcj.2019.0105

Verify or expand the search:

Other recruiting trials for Cardiovascular Disease

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07293260 — Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial · Phase 3 · recruiting
NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
NCT06625073 — Randomized Trial of SGLT2i in Heart Transplant Recipients · Phase 4 · recruiting
NCT06485700 — Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A) · NA · recruiting

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02931500 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 10 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02931500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing